Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Financing Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-77 Cr₹241 Cr₹280 Cr₹23 Cr₹-44 Cr

What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES is ₹-77 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-77 Cr
Mar2025₹241 Cr
Mar2024₹280 Cr
Mar2023₹23 Cr
Mar2022₹-44 Cr

How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-77 Cr
Negative
Mar2025 ₹241 Cr
-13.91
Mar2024 ₹280 Cr
1,129.76
Mar2023 ₹23 Cr
Positive
Mar2022 ₹-44 Cr -

Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,299.2 Cr -2.1% 2.8% -14.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹441,478.0 Cr -0.2% -3.2% 12.7% Stock Analytics
DIVIS LABORATORIES ₹253,031.0 Cr 2% 5.3% 57.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,216.0 Cr -2.4% -3.1% 36.4% Stock Analytics
CIPLA ₹112,205.0 Cr 0.6% -2.2% -9.4% Stock Analytics
DR REDDYS LABORATORIES ₹102,040.0 Cr 0.9% 4% -7.6% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-2.1%

2.8%

-14.9%

SENSEX

-2.8%

-6.1%

-11.9%


You may also like the below Video Courses